CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-012115
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Mothers against decapentaplegic homolog 4 
Protein Synonyms/Alias
 MAD homolog 4; Mothers against DPP homolog 4; Deletion target in pancreatic carcinoma 4; SMAD family member 4; SMAD 4; Smad4; hSMAD4 
Gene Name
 SMAD4 
Gene Synonyms/Alias
 DPC4; MADH4 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
37GESETFAKRAIESLVacetylation[1]
45RAIESLVKKLKEKKDacetylation[1]
70TNGAHPSKCVTIQRTubiquitination[2]
106WRWPDLHKNELKHVKacetylation[1]
113KNELKHVKYCQYAFDsumoylation[3, 4, 5]
113KNELKHVKYCQYAFDubiquitination[2, 6, 7, 8, 9]
159APSSMMVKDEYVHDFsumoylation[3, 4, 5, 10, 11]
385RARLHIGKGVQLECKubiquitination[2, 8]
428APGDAVHKIYPSAYIacetylation[1]
507ILRMSFVKGWGPDYPacetylation[1]
519DYPRQSIKETPCWIEubiquitination[2, 6, 9]
Reference
 [1] Lysine acetylation targets protein complexes and co-regulates major cellular functions.
 Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M.
 Science. 2009 Aug 14;325(5942):834-40. [PMID: 19608861]
 [2] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [3] Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
 Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F, Feng XH.
 J Biol Chem. 2003 May 23;278(21):18714-9. [PMID: 12621041]
 [4] Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
 Lee PS, Chang C, Liu D, Derynck R.
 J Biol Chem. 2003 Jul 25;278(30):27853-63. [PMID: 12740389]
 [5] Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1.
 Liang M, Melchior F, Feng XH, Lin X.
 J Biol Chem. 2004 May 28;279(22):22857-65. [PMID: 15028714]
 [6] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [7] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
 Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
 Mol Cell Proteomics. 2012 May;11(5):148-59. [PMID: 22505724]
 [8] Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
 Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, Nielsen ML, Bekker-Jensen S, Mailand N, Choudhary C.
 Nat Cell Biol. 2012 Oct;14(10):1089-98. [PMID: 23000965]
 [9] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties.
 Chen Z, Zhou Y, Song J, Zhang Z.
 Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [PMID: 23603789]
 [10] Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
 Ohshima T, Shimotohno K.
 J Biol Chem. 2003 Dec 19;278(51):50833-42. [PMID: 14514699]
 [11] Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
 Chang CC, Lin DY, Fang HI, Chen RH, Shih HM.
 J Biol Chem. 2005 Mar 18;280(11):10164-73. [PMID: 15637079
Functional Description
 Common SMAD (co-SMAD) is the coactivator and mediator of signal transduction by TGF-beta (transforming growth factor). Component of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the nucleus and is required for the TGF-mediated signaling. Promotes binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an activation function required for SMAD1 or SMAD2 to stimulate transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex which forms at the AP1 promoter site; required for syngernistic transcriptional activity in response to TGF-beta. May act as a tumor suppressor. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14- 3-3 protein YWHAQ which acts as a negative regulator. 
Sequence Annotation
 DOMAIN 18 142 MH1.
 DOMAIN 323 552 MH2.
 REGION 275 320 SAD.
 METAL 71 71 Zinc (By similarity).
 METAL 115 115 Zinc (By similarity).
 METAL 127 127 Zinc (By similarity).
 METAL 132 132 Zinc (By similarity).
 MOD_RES 37 37 N6-acetyllysine.
 MOD_RES 428 428 N6-acetyllysine.
 MOD_RES 507 507 N6-acetyllysine.
 CROSSLNK 519 519 Glycyl lysine isopeptide (Lys-Gly)  
Keyword
 3D-structure; Acetylation; Complete proteome; Cytoplasm; Disease mutation; DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Transcription; Transcription regulation; Ubl conjugation; Zinc. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 552 AA 
Protein Sequence
MDNMSITNTP TSNDACLSIV HSLMCHRQGG ESETFAKRAI ESLVKKLKEK KDELDSLITA 60
ITTNGAHPSK CVTIQRTLDG RLQVAGRKGF PHVIYARLWR WPDLHKNELK HVKYCQYAFD 120
LKCDSVCVNP YHYERVVSPG IDLSGLTLQS NAPSSMMVKD EYVHDFEGQP SLSTEGHSIQ 180
TIQHPPSNRA STETYSTPAL LAPSESNATS TANFPNIPVA STSQPASILG GSHSEGLLQI 240
ASGPQPGQQQ NGFTGQPATY HHNSTTTWTG SRTAPYTPNL PHHQNGHLQH HPPMPPHPGH 300
YWPVHNELAF QPPISNHPAP EYWCSIAYFE MDVQVGETFK VPSSCPIVTV DGYVDPSGGD 360
RFCLGQLSNV HRTEAIERAR LHIGKGVQLE CKGEGDVWVR CLSDHAVFVQ SYYLDREAGR 420
APGDAVHKIY PSAYIKVFDL RQCHRQMQQQ AATAQAAAAA QAAAVAGNIP GPGSVGGIAP 480
AISLSAAAGI GVDDLRRLCI LRMSFVKGWG PDYPRQSIKE TPCWIEIHLH RALQLLDEVL 540
HTMPIADPQP LD 552 
Gene Ontology
 GO:0032444; C:activin responsive factor complex; IDA:BHF-UCL.
 GO:0005813; C:centrosome; IDA:HPA.
 GO:0005829; C:cytosol; TAS:Reactome.
 GO:0071141; C:SMAD protein complex; IDA:UniProtKB.
 GO:0003682; F:chromatin binding; IEA:Compara.
 GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB.
 GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
 GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Compara.
 GO:0030616; F:transforming growth factor beta receptor, common-partner cytoplasmic mediator activity; IDA:BHF-UCL.
 GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
 GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Compara.
 GO:0008283; P:cell proliferation; IEA:Compara.
 GO:0048589; P:developmental growth; IEA:Compara.
 GO:0007492; P:endoderm development; IEA:Compara.
 GO:0048859; P:formation of anatomical boundary; IEA:Compara.
 GO:0001702; P:gastrulation with mouth forming second; IEA:Compara.
 GO:0001701; P:in utero embryonic development; IEA:Compara.
 GO:0007498; P:mesoderm development; IEA:Compara.
 GO:0072133; P:metanephric mesenchyme morphogenesis; IEA:Compara.
 GO:0060548; P:negative regulation of cell death; IEA:Compara.
 GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL.
 GO:0008285; P:negative regulation of cell proliferation; IEA:Compara.
 GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL.
 GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
 GO:0072134; P:nephrogenic mesenchyme morphogenesis; IEA:Compara.
 GO:0014033; P:neural crest cell differentiation; IEA:Compara.
 GO:0048663; P:neuron fate commitment; IEA:Compara.
 GO:0060021; P:palate development; ISS:BHF-UCL.
 GO:0030513; P:positive regulation of BMP signaling pathway; IMP:BHF-UCL.
 GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:BHF-UCL.
 GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; ISS:BHF-UCL.
 GO:0060391; P:positive regulation of SMAD protein import into nucleus; ISS:BHF-UCL.
 GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
 GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL.
 GO:0051098; P:regulation of binding; IEA:Compara.
 GO:0051797; P:regulation of hair follicle development; IEA:Compara.
 GO:0032909; P:regulation of transforming growth factor beta2 production; IMP:BHF-UCL.
 GO:0001666; P:response to hypoxia; IMP:BHF-UCL.
 GO:0048733; P:sebaceous gland development; IEA:Compara.
 GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL.
 GO:0060395; P:SMAD protein signal transduction; IDA:BHF-UCL.
 GO:0032525; P:somite rostral/caudal axis specification; IEA:Compara.
 GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
 GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL. 
Interpro
 IPR013790; Dwarfin.
 IPR003619; MAD_homology1_Dwarfin-type.
 IPR013019; MAD_homology_MH1.
 IPR017855; SMAD_dom-like.
 IPR001132; SMAD_dom_Dwarfin-type.
 IPR008984; SMAD_FHA_domain. 
Pfam
 PF03165; MH1
 PF03166; MH2 
SMART
 SM00523; DWA
 SM00524; DWB 
PROSITE
 PS51075; MH1
 PS51076; MH2 
PRINTS